Select publications authored by our scientists.
- Immunology and Infectious Disease
- 2026
Brostoff T, Pires J, Rose A, Cohen-Davidyan T, Castillo D, Murphy BG, Reagan KL
Treatment of non-effusive feline infectious peritonitis using oral remdesivir or GS-441524: a randomized, double-blind, non-inferiority trial
2025
Wanakumjorn P, Kimura K, Castillo D, McLarty E, Formaker R, Qiao R, Farrell K, Brostoff T, Ramarapu R, Pires J, Cohen-Davidyan T, Cassano J, Murphy B, Reagan K, Kol A
Mesenchymal stem/stromal cell therapy improves immune recovery in a feline model of severe coronavirus infection
2024
Murphy BG, Castillo D, Neely NE, Kol A, Brostoff T, Grant CK, Reagan KL
Serologic, Virologic and Pathologic Features of Cats with Naturally Occurring Feline Infectious Peritonitis Enrolled in Antiviral Clinical Trials
2024
Reagan KL, Brostoff T, Pires J, Rose A, Castillo D, Murphy BG
Open label clinical trial of orally administered molnupiravir as a first-line treatment for naturally occurring effusive feline infectious peritonitis
2022
Skorupski KA, Byrne BA, Palm CA, Burton JH
Prospective comparison of prostatic aspirate culture and cystocentesis urine culture for detection of bacterial infection in dogs with prostatic neoplasia - Oncology
- 2025
Grandis JR, Skorupski KA, Cheng N, Cui Z, Li H, Woerner LC, Gencel-Augusto J, Zeng Y, Shiah JV, Bhola NE, Sen M, Blum K, Kim MO, York D, Rebhun RB, Chang H, Murad NF, Olshen AB, Sparger EE, Johnson DE
Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer
2025
Luker ME, York D, Al-Nadaf S, Johnson EG, Withers SS, Cruz SM, Lejeune A, Skorupski KA, Young J, Cohen-Davidyan T, Sparger EE, Culp WT, Murphy WJ, Kent MS, Canter RJ, Rebhun RB
Evaluating the impact of doxorubicin preconditioning on the efficacy of inhaled recombinant human IL-15 immunotherapy in dogs with pulmonary metastasis
2025
Rebhun RB, Cruz SM, York D, Mazcko CN, Razmara AM, Patkar S, Judge SJ, Sholevar CJ, Shah RK, Zamora AE, Al-Nadaf S, Vail DM, Fan TM, Burton JH, Luker ME, Skorupski KA, Lejeune AT, Woolard K, Stewart SL, Sparger EE, Young J, Cohen-Davidyan T, Huang E, Beck JA, Murphy WJ, Kent MS, Culp WTN, LeBlanc AK, Canter RJ
Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma
2025
Razmara AM, Lammers M, Judge SJ, Sholevar CJ, Murphy WJ, Gaskill CE, Culp WTN, Gingrich AA, Morris ZS, Rebhun RB, Brown CT, Vail DM, Kent MS, Canter RJ
Comparative transcriptomic analysis of tumor- infiltrating canine natural killer cells and candidate biomarkers from first-in-dog NK immunotherapy trials
2024
Razmara AM, Farley LE, Harris RM, Judge SJ, Lammers M, Iranpur KR, Johnson EG, Dunai C, Murphy WJ, Brown CT, Rebhun RB, Kent MS, Canter RJ
Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer
2024
Burton JH, Vail DM, Willcox JL, Al-Nadaf S, Adrianowycz S, Biggs D, Hayim R, Magee K, McMahon R, Mok I, Picone AM, Ralston J, Smith BM, Uyehara R, Willis AL, Johnston SA, Thamm DH
Low prevalence of occult cancer diagnosis when screening healthy, higher-risk, middle-aged to older dogs
2024
Burton JH, Johnston SA, Vail DM, Eickhoff JC, Sykes KF, Brown JR, Shen L, Gervassi A, Page RL, Willcox JL, Al-Nadaf S, Willis AL, Biggs D, Ralston J, Mok I, Kurzman ID, Huelsmeyer MK, Hayim R, Smith BM, Thamm DH
Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogs
2023
Veluvolu S, Willcox JL, Skorupski KA, Al-Nadaf S, Rebhun R, Wittenburg L
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high-grade multicentric lymphoma
2022
Al-Nadaf S, Wittenburg LA, Skorupski KA, Burton JH
Population pharmacokinetics identifies rapid gastrointestinal absorption and plasma clearance of oral chlorambucil administered to cats with indolent lymphoproliferative malignancies
2022
Culp WTN, Johnson EG, Giuffrida MA, Rebhun RB, Cawthra JK, Schwanz HA, Burton JH, Kent MS.
Evaluation of the use of a novel bioabsorbable polymer drug-eluting microsphere for transarterial embolization of hepatocellular neoplasia in dogs
2022
Rebhun RB, York D, Cruz SM, Judge SJ, Razmara AM, Farley LE, Brady RV, Johnson EG, Burton JH, Willcox J, Wittenburg LA, Woolard K, Dunai C, Stewart SL, Sparger EE, Withers SS, Gingrich AA, Skorupski KA, Al-Nadaf S, LeJeune AT, Culp WT, Murphy WJ, Kent MS, Canter RJ
Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of response
2017
Pollard RE, Watson KD, Hu X, Ingham E, Ferrara KW
Feasibility of quantitative contrast ultrasound imaging of bladder tumors in dogs